IMMULISA CELIAC TTG IGA AND IGG ANTIBODY ELISA— 510(k) K091520

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K091520 for IMMULISA CELIAC TTG IGA AND IGG ANTIBODY ELISA, Substantially Equivalent on 2010-03-10. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant
Immco Diagnostics, Inc.
Product code
Code MVM
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Buffalo, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.